Monitoring of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Sensitizing and Resistance Mutations in the Plasma DNA of Patients With Advanced Non–Small Cell Lung Cancer During Treatment With Erlotinib

BACKGROUND: The feasibility of monitoring epidermal growth factor receptor (EGFR) mutations in plasma DNA from patients with advanced non–small cell lung cancer (NSCLC) during treatment with erlotinib and its relation to disease progression was investigated. METHODS: The amount of EGFR-mutant DNA wa...

Full description

Saved in:
Bibliographic Details
Published in:Cancer
Main Authors: Sorensen, Boe S, Wu, Lin, Wei, Wen, Tsai, Julie, Weber, Britta, Nexo, Ebba, Meldgaard, Peter
Format: Artigo
Language:Inglês
Published: BlackWell Publishing Ltd 2014
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4303984/
https://ncbi.nlm.nih.gov/pubmed/25103305
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.28964
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items